[go: up one dir, main page]

AUPN523995A0 - Method for producing phage display vectors - Google Patents

Method for producing phage display vectors

Info

Publication number
AUPN523995A0
AUPN523995A0 AUPN5239A AUPN523995A AUPN523995A0 AU PN523995 A0 AUPN523995 A0 AU PN523995A0 AU PN5239 A AUPN5239 A AU PN5239A AU PN523995 A AUPN523995 A AU PN523995A AU PN523995 A0 AUPN523995 A0 AU PN523995A0
Authority
AU
Australia
Prior art keywords
phage display
display vectors
producing phage
producing
vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPN5239A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CRC for Biopharmaceutical Research Pty Ltd
Original Assignee
CRC for Biopharmaceutical Research Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CRC for Biopharmaceutical Research Pty Ltd filed Critical CRC for Biopharmaceutical Research Pty Ltd
Priority to AUPN5239A priority Critical patent/AUPN523995A0/en
Publication of AUPN523995A0 publication Critical patent/AUPN523995A0/en
Priority to CA002231045A priority patent/CA2231045A1/en
Priority to EP96928283A priority patent/EP0850309A1/en
Priority to PCT/AU1996/000555 priority patent/WO1997009436A1/en
Priority to AU67823/96A priority patent/AU6782396A/en
Priority to JP9510704A priority patent/JPH10511001A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AUPN5239A 1995-09-05 1995-09-05 Method for producing phage display vectors Abandoned AUPN523995A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AUPN5239A AUPN523995A0 (en) 1995-09-05 1995-09-05 Method for producing phage display vectors
CA002231045A CA2231045A1 (en) 1995-09-05 1996-09-05 Method for producing phage display vectors
EP96928283A EP0850309A1 (en) 1995-09-05 1996-09-05 Method for producing phage display vectors
PCT/AU1996/000555 WO1997009436A1 (en) 1995-09-05 1996-09-05 Method for producing phage display vectors
AU67823/96A AU6782396A (en) 1995-09-05 1996-09-05 Method for producing phage display vectors
JP9510704A JPH10511001A (en) 1995-09-05 1996-09-05 Method for producing phage display vector

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPN5239A AUPN523995A0 (en) 1995-09-05 1995-09-05 Method for producing phage display vectors

Publications (1)

Publication Number Publication Date
AUPN523995A0 true AUPN523995A0 (en) 1995-09-28

Family

ID=3789568

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPN5239A Abandoned AUPN523995A0 (en) 1995-09-05 1995-09-05 Method for producing phage display vectors

Country Status (5)

Country Link
EP (1) EP0850309A1 (en)
JP (1) JPH10511001A (en)
AU (1) AUPN523995A0 (en)
CA (1) CA2231045A1 (en)
WO (1) WO1997009436A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143557A (en) 1995-06-07 2000-11-07 Life Technologies, Inc. Recombination cloning using engineered recombination sites
US6720140B1 (en) 1995-06-07 2004-04-13 Invitrogen Corporation Recombinational cloning using engineered recombination sites
US6964861B1 (en) 1998-11-13 2005-11-15 Invitrogen Corporation Enhanced in vitro recombinational cloning of using ribosomal proteins
NZ500843A (en) 1995-06-07 2002-03-28 Invitrogen Corp A method of DNA recombination which is selectable to select for cells containing a product and against cells only harbouring the insert donor
US6051409A (en) 1995-09-25 2000-04-18 Novartis Finance Corporation Method for achieving integration of exogenous DNA delivered by non-biological means to plant cells
US5851808A (en) 1997-02-28 1998-12-22 Baylor College Of Medicine Rapid subcloning using site-specific recombination
US7351578B2 (en) 1999-12-10 2008-04-01 Invitrogen Corp. Use of multiple recombination sites with unique specificity in recombinational cloning
US7393632B2 (en) 1999-12-10 2008-07-01 Invitrogen Corp. Use of multiple recombination sites with unique specificity in recombinational cloning
AU752704B2 (en) 1997-10-24 2002-09-26 Invitrogen Corporation Recombinational cloning using nucleic acids having recombination sites
CA2305866A1 (en) 1997-11-18 1999-05-27 Pioneer Hi-Bred International, Inc. A method for directional stable transformation of eukaryotic cells
CA2306053C (en) 1997-11-18 2003-01-21 Pioneer Hi-Bred International, Inc. Mobilization of viral genomes from t-dna using site-specific recombination systems
US7102055B1 (en) 1997-11-18 2006-09-05 Pioneer Hi-Bred International, Inc. Compositions and methods for the targeted insertion of a nucleotide sequence of interest into the genome of a plant
DK1032680T3 (en) 1997-11-18 2006-05-22 Pioneer Hi Bred Int A novel method for integrating foreign DNA into eukaryotic genomes
JP2002522029A (en) 1998-07-27 2002-07-23 ジェネンテック・インコーポレーテッド Improved transformation efficiency in phage display by modification of coat protein
DE60042969D1 (en) 1999-03-02 2009-10-29 Life Technologies Corp PREPARATIONS AND METHODS FOR USE IN RECOMBINATORY CLONING OF NUCLEIC ACIDS
US7244560B2 (en) 2000-05-21 2007-07-17 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US7560622B2 (en) 2000-10-06 2009-07-14 Pioneer Hi-Bred International, Inc. Methods and compositions relating to the generation of partially transgenic organisms
US20030235814A1 (en) * 2002-06-19 2003-12-25 Los Alamos National Laboratory Compositions and methods for selecting open reading frames
JP2007512838A (en) 2003-12-01 2007-05-24 インヴィトロジェン コーポレーション Nucleic acid molecules containing recombination sites and methods of use thereof
ATE523603T1 (en) 2008-11-21 2011-09-15 Chimera Biotec Gmbh CONJUGATE COMPLEXES FOR ANALYTE DETECTION
US9712606B2 (en) * 2014-05-21 2017-07-18 Nasdaq Technology Ab Efficient and reliable host distribution of totally ordered global state
JP6328851B2 (en) 2015-06-24 2018-05-23 Ｊｃｒファーマ株式会社 Anti-human transferrin receptor antibodies that cross the blood-brain barrier
TWI833178B (en) 2016-12-26 2024-02-21 日商Ｊｃｒ製藥股份有限公司 Novel anti-human transferrin receptor antibodies cross the blood-brain barrier
US12214007B2 (en) 2016-12-26 2025-02-04 Jcr Pharmaceuticals Co., Ltd. Fusion protein including BDNF
EA202091816A1 (en) 2018-02-05 2020-10-26 Джей Си Ар ФАРМАСЬЮТИКАЛЗ КО., ЛТД. METHOD OF DRUG DELIVERY TO MUSCLE
EP4424325A4 (en) 2021-11-19 2026-01-14 Japan Chem Res PEPTIDE WITH AFFINITY TO THE HUMAN TRANSFERRIN RECEPTOR
EP4653533A1 (en) 2023-02-07 2025-11-26 JCR Pharmaceuticals Co., Ltd. Human transferrin receptor-avid peptide

Also Published As

Publication number Publication date
EP0850309A1 (en) 1998-07-01
CA2231045A1 (en) 1997-03-13
JPH10511001A (en) 1998-10-27
WO1997009436A1 (en) 1997-03-13

Similar Documents

Publication Publication Date Title
AUPN523995A0 (en) Method for producing phage display vectors
AU4716296A (en) Process for producing thietanones
AU4698396A (en) Process for modifying surfaces
EP0772180A3 (en) Video display apparatus
AU6666196A (en) Cooling apparatus
EP0776070A3 (en) Connecting apparatus
AU691390B2 (en) Process for producing N-arylhydroxylamines and N-hetarylhydroxylamines
EP0753415A3 (en) Image forming method
AU4882996A (en) Method for producing fluoroalkanes
AU7591896A (en) Method for motion estimation
AU7414196A (en) Process for producing etoposide
IL119235A0 (en) Display forming method
AU1118797A (en) Process
AU6782396A (en) Method for producing phage display vectors
AU1101797A (en) Method for making fluoroalkanols
HUP9602988A2 (en) Process for producing 2-chloracrylnitril
AU1177197A (en) Improved process for producing 5-formylthiazol
AU5271296A (en) Novel method
PL323389A1 (en) Caprolaktam producing method
AU7694596A (en) Process for producing 1-aminohydantoin
AU5485596A (en) Process for making 1-hydroxybisphosphonates
HUT76300A (en) Process for producing veratrumaldehyde
GB2304416B (en) NMR method
AU2055095A (en) Process
AU672575B3 (en) Refrigeration apparatus